Lafourcade Carlos A, Zhang Longhua, Alger Bradley E
Department of Physiology, Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD, USA.
PLoS One. 2009 Jul 1;4(7):e6122. doi: 10.1371/journal.pone.0006122.
Metabotropic glutamate receptors (mGluRs) are ubiquitous throughout the body, especially in brain, where they mediate numerous effects. MGluRs are classified into groups of which group I, comprising mGluRs 1 and 5, is especially important in neuronal communication. Group I actions are often investigated with the selective agonist, S-3,5-dihydroxyphenylglycine (DHPG). Despite the selectivity of DHPG, its use has often led to contradictory findings. We now report that a particular commercial preparation of DHPG can produce mGluR-independent effects. These findings may help reconcile some discrepant reports.
We carried out electrophysiological recordings in the rat in vitro hippocampal slice preparation, focusing mainly on pharmacologically isolated GABA(A)-receptor-mediated synaptic currents.
While preparations of DHPG from three companies suppressed GABAergic transmission in an mGluR-dependent way, one batch had an additional, unusual effect. Even in the presence of antagonists of mGluRs, it caused a reversible, profound suppression of inhibitory transmission. This mGluR-independent action was not due to a higher potency of the compound, or its ability to cause endocannabinoid-dependent responses. Field potential recordings revealed that glutamatergic transmission was not affected, and quantal analysis of GABA transmission confirmed the unusual effect was on GABA release, and not GABA(A) receptors. We have not identified the responsible factor in the DHPG preparation, but the samples were 99% pure as determined by HPLC and NMR analyses.
In certain respects our observations with the anomalous batch strikingly resemble some published reports of unusual DHPG effects. The present findings could therefore contribute to explaining discrepancies in the literature. DHPG is widely employed to study mGluRs in different systems, hence rigorous controls should be performed before conclusions based on its use are drawn.
代谢型谷氨酸受体(mGluRs)在全身广泛存在,尤其是在大脑中,它们介导多种效应。mGluRs分为不同组,其中包括mGluR1和mGluR5的I组在神经元通讯中尤为重要。I组的作用通常使用选择性激动剂S-3,5-二羟基苯甘氨酸(DHPG)进行研究。尽管DHPG具有选择性,但它的使用常常导致相互矛盾的结果。我们现在报告,一种特定的市售DHPG制剂可产生与mGluR无关的效应。这些发现可能有助于调和一些相互矛盾的报道。
我们在大鼠体外海马脑片制备中进行电生理记录,主要关注药理学分离的GABA(A)受体介导的突触电流。
虽然来自三家公司的DHPG制剂以mGluR依赖的方式抑制GABA能传递,但一批制剂有额外的异常效应。即使在存在mGluRs拮抗剂的情况下,它也会导致抑制性传递的可逆性、深度抑制。这种与mGluR无关的作用不是由于该化合物的效力更高,也不是由于其引起内源性大麻素依赖性反应的能力。场电位记录显示谷氨酸能传递未受影响,GABA传递的量子分析证实异常效应是对GABA释放的影响,而不是对GABA(A)受体的影响。我们尚未确定DHPG制剂中的责任因素,但通过HPLC和NMR分析测定,样品纯度为99%。
在某些方面,我们对异常批次的观察结果与一些已发表的关于DHPG异常效应的报道惊人地相似。因此,本研究结果可能有助于解释文献中的差异。DHPG被广泛用于研究不同系统中的mGluRs,因此在基于其使用得出结论之前应进行严格的对照。